Appendix D
Forum on Emerging Infections Membership and Publications Board on Global Health
FORUM ON EMERGING INFECTIONS
ADEL MAHMOUD (Chair), President, Merck Vaccines, Whitehouse Station, New Jersey
STANLEY LEMON (Vice-Chair), Dean, School of Medicine, The University of Texas Medical Branch, Galveston, Texas
DAVID ACHESON, Chief Medical Officer, Center for Food Safety and Applied Nutrition, Food and Drug Administration, Rockville, Maryland
STEVEN BRICKNER, Research Advisor, Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut
GAIL CASSELL, Vice President, Scientific Affairs, Eli Lilly & Company, Indianapolis, Indiana
GORDON DEFRIESE, Professor of Social Medicine, University of North Carolina, Chapel Hill, North Carolina
CEDRIC DUMONT, Medical Director, Department of State and the Foreign Service, Washington, DC
JESSE GOODMAN, Deputy Director, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland
EDUARDO GOTUZZO, Director, Instituto de Medicina Tropical, “Alexander von Humbolt” Universidad Peruana Cayetano Herdia, Lima, Peru
RENU GUPTA, Vice President and Head, U.S. Clinical Research and Development, and Head, Global Cardiovascular, Metabolic, Endocrine, and G.I. Disorders, Novartis Corporation, East Hanover, New Jersey
MARGARET HAMBURG, Vice President for Biological Programs, Nuclear Threat Initiative, Washington, DC
CAROLE HEILMAN, Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
DAVID HEYMANN, Executive Director, Communicable Diseases, World Health Organization, Geneva, Switzerland
JAMES HUGHES, Assistant Surgeon General and Director, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
SAMUEL KATZ, Wilburt C. Davison Professor and Chairman Emeritus, Duke University Medical Center, Durham, North Carolina
PATRICK KELLEY, Colonel, Director, Department of Defense Global Emerging Infections System, Walter Reed Army Institute of Research, Silver Spring, Maryland
MARCELLE LAYTON, Assistant Commissioner, Bureau of Communicable Diseases, New York City Department of Health, New York, New York
JOSHUA LEDERBERG, Raymond and Beverly Sackler Foundation Scholar, The Rockefeller University, New York, New York
CARLOS LOPEZ, Research Fellow, Research Acquisitions, Eli Lilly Research Laboratories, Indianapolis, Indiana
LYNN MARKS, Global Head of Infectious Diseases, GlaxoSmithKline, Collegeville, Pennsylvania
STEPHEN MORSE, Director, Center for Public Health Preparedness, Columbia University, New York, New York
MICHAEL OSTERHOLM, Director, Center for Infectious Disease Research and Policy, and Professor, School of Public Health, University of Minnesota, Minneapolis, Minnesota
GARY ROSELLE, Program Director for Infectious Diseases, VA Central Office, Veterans Health Administration, Department of Veterans Affairs, Washington, DC
DAVID SHLAES, Executive Vice President for Research and Development, Idenix, Cambridge, Massachusetts
JANET SHOEMAKER, Director, Office of Public Affairs, American Society for Microbiology, Washington, DC
P. FREDRICK SPARLING, J. Herbert Bate Professor Emeritus of Medicine, Microbiology, and Immunology, University of North Carolina, Chapel Hill, North Carolina
MICHAEL ZEILINGER, Infectious Disease Team Leader, Office of Health and Nutrition, U.S. Agency for International Development, Washington, DC
Liaisons
ENRIQUETA BOND, President, Burroughs Wellcome Fund, Research Triangle Park, North Carolina
NANCY CARTER-FOSTER, Director, Program for Emerging Infections and HIV/AIDS, U.S. Department of State, Washington, DC
EDWARD McSWEEGAN, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
STEPHEN OSTROFF, Associate Director for Epidemiologic Science, National Center for Infectious Diseases. Centers for Disease Control and Prevention, Atlanta, Georgia
BOARD ON GLOBAL HEALTH
DEAN T. JAMISON (Chair), Senior Fellow, Fogarty International Center, National Institutes of Health
YVES BERGEVIN, Chief, Health Section, UNICEF
PATRICIA DANZON, Professor, Health Care Systems Department, University of Pennsylvania
RICHARD FEACHEM, Interim Secretariat, Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva
NOREEN GOLDMAN, Professor, Office of Population Research, Princeton University, Princeton, New Jersey
MARGARET HAMBURG, Vice President for Biological Programs, Nuclear Threat Initiative, Washington, DC
GERALD KEUSCH, Director, Fogarty International Center, National Institutes of Health
ARTHUR KLEINMAN, Maude and Lillian Presley Professor of Medical Anthropology/ Professor of Psychiatry and Social Medicine, Harvard Medical School
ADEL MAHMOUD, President, Merck Vaccines
JOHN WYN OWEN, Secretary, Nuffield Trust, London
ALLAN ROSENFIELD, Dean, Mailman School of Public Health, Columbia University
SUSAN SCRIMSHAW, Dean, School of Public Health, University of Illinois at Chicago
Staff
JUDITH BALE, Director, Board on Global Health (retired December 2002)
STACEY L. KNOBLER, Director, Forum on Emerging Infections
MARK S. SMOLINSKI, Senior Program Officer
PATRICIA CUFF, Research Associate
MARJAN NAJAFI, Research Associate
KATHERINE OBERHOLTZER, Project Assistant
JASON PELLMAR, Project Assistant
PUBLICATIONS
The Infectious Etiology of Chronic Diseases
in press
The Impact of Globalization on Infectious Disease Emergence and Control
in press
The Resistance Phenomenon in Microbes and Infectious Disease Vectors
Implications for Human Health and Strategies for Containmemt
2003
The Emergence of Zoonotic Diseases
Understanding the Impact on Animal and Human Health
2002
Considerations for Viral Disease Eradication
Lessons Learned and Future Strategies
2002
Biological Threats and Terrorism
Assessing the Science and Response Capabilities
2002
Emerging Infectious Diseases from the Global to Local Perspective
2002
Managed Care Systems and Emerging Infections
Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention
2000
Antimicrobial Resistance
Issues and Options
1998
Orphans and Incentives
Developing Technologies to Address Emerging Infections
1997